New Drug Pricing Regime Highlights Two Tiered Approach

Other firms argue that the 10% reduction is too much and that the reference countries should have included more developing markets with similar economic conditions to Egypt for a better alignment of purchasing power. Lowering the price of patented medicines is likely to be a political tool for raising public favour - although even patient rights groups have contested that access to medicines will not actually increase with the new pricing strategy.

To read the full article, please choose one of the following options: